Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunitiesDr. Sabine ...

According to iSpot.TV’s analysis of January TV drug ad spending data, Novartis’ prostate cancer drug Pluvicto swooped in to take the No. 1 spot on the list, with more than $47 million spent ...

Thursday 6 February will mark 67 years since the Munich Air Disaster, the darkest day in our history, where 23 people, including eight Manchester United players and three officials, tragically ...

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials Individual patient data of neoadjuvant RCTs ...

Bayern Munich 3-1 Slovan Bratislava Goals: 1-0 Müller 8' (assist: Kimmich), 2-0 Kane (assist: Musiala), 3-0 Coman 84', 3-1 Tolić 90' Bayern knew they had to win to have any chance of bypassing ...

Bayern Munich and Slovan Bratislava will meet in a competitive fixture for the first time; the Germans last faced a Slovakian opponent in European competition in the 1988-89 UEFA Cup, beating DAC ...

Dinamo Zagreb, who host Milan, can leap up to 11 points but their heavy defeat to Bayern Munich earlier in the competition means they would find it difficult to finish above Club Brugge on goal ...

But Steinfeld is gearing up for another arena. Steinfeld is teaming up with pharmaceutical company Novartis to raise awareness about breast cancer with a bold and empowering commercial that will ...

To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s biggest stages. The drugmaker’s first-ever Super Bowl ad is set to ...

Existing investor F-Prime Capital also joined the round, with participation from new investors Novartis Venture Fund, RiverVest Venture Partners, funds managed by abrdn, Pictet Alternative ...

From my colleague Allison DeAngelis: A new cancer treatment developed by ITM Isotope Technologies Munich SE has succeeded in a Phase 3 trial, setting the stage for a competitor to Novartis ...